Short Description
Study of clinical trial protocols incorporating computational biomarkers for non-genetic neurodegenerative diseases. The goal is to investigate the feasibility and potential benefits of using these biomarkers, identify the most relevant and informative markers for different disease types, and evaluate their ability to monitor disease progression and predict treatment outcomes.


